Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
3d
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.
Weight loss drugs like Ozempic and Wegovy have dominated the diet discussion for the past few years. But this trend leaves many people wondering: What role does weight-loss surgery play in an ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback